21st Century Cures Act Passes House with Overwhelming Bipartisan Support

ME/CFS advocates have been eagerly awaiting passage of the 21st Century Cures act since it was initially introduced in 2013, given it was originally written to increase NIH funding and fast-track research and treatment development. On Wednesday, November 30, a compromise bill with modified provisions from the original 21st Century Cures Act swept the House in a 392 – 26 vote. “We have listened to every group out there,” said Representative Fred Upton, author of the bill. “I think we have a pretty good bipartisan bill that’s going to meet everyone’s test of how legislation should be done.” Had the bill not been passed before the end of December, the process to craft it would have had to start again from scratch in the new year.
While the new $6.3 billion compromise funnels new funds to the NIH, those funds are targeted for specific programs such as The Precision Medicine Initiative, Cancer Moonshot, and the BRAIN Initiative and are unlikely to benefit ME/CFS research directly. Additionally, unlike the original bill, these funds are subject to yearly congressional review and can potentially be withheld or redirected.
The compromise package passed this week lost many key initiatives supported by our organization, such as the “OPEN” Act, incentives for misunderstood disease research, and flexible funding for the NIH. Additional elements, such as funds to combat opioid addiction, provisions addressing Medicare, and mental healthcare streamlining, were added in the compromise.
A few key elements that remain in the current legislation which could positively impact ME/CFS include

  • Increased accountability at the NIH

In a new process that is welcome news to many ME/CFS advocates, the 21st Century Cures Act provides increased oversight, accountability, and transparency at the NIH. The new law requires the NIH to issue and publish a strategic plan and increases accountability at the NIH overall, including the system used in the distribution of grant awards. SMCI has continually pressed the NIH for this information regarding ME/CFS with virtually no success.

  • Removing barriers to increased research collaboration

Provisions directed at data standardization, data collection and sharing, and clinical trial reporting are designed to increase collaboration between researchers for better results. There are also provisions to modernize clinical trials and increase the use of patient-generated registries, both of which have been key barriers in ME/CFS research.

  • Incorporating the patient perspective

One of the most controversial parts of the bill increases the ability for researchers and the Food and Drug Administration (FDA to consider the direct experience of patients to modify and improve potential treatments. This new, structured framework would take patient reports into account when analyzing a drug’s benefits and risks.

  • Improved biomarker qualification

One additional provision added to the 21st Century Cures Act is called the “Drug Development Tools Qualification Program.” This section will create a new review process at the FDA for biomarkers and other development tools to expedite drug development and reduce the likelihood of development failures.
Go here to read the SMCI’s previous coverage of the 21st Century Cures Act.
http://solvecfs.org/21st-century-cures-act-passes-house-with-overwhelming-bipartisan-support/

Facebook
Twitter
WhatsApp
Email

1 thought on “21st Century Cures Act Passes House with Overwhelming Bipartisan Support”

  1. This bill is a giveaway to Big Pharma, whose lobbyists wrote it. It has its good points, but in sum, it’s all about short-term bottom line for an already bloated industry, putting patient safety at risk, both short- and long-term. This bill may fast-track potential treatments for M.E., but it will also fast-track potential M.E. triggers!

Comments are closed.

Latest News

blue rectangle image with the NIH logo in the top left hand corner. the words: NIH MECFS Research Roadmap Update Public comments open until March 8th appear in the middle of the image. the meaction logo is in the bottom right hand corner.

NIH ME/CFS Research Roadmap Update–Public Comment Period Now Open

The NIH ME/CFS Research Roadmap public comment period is open now with a deadline of March 8th.  #MEAction is a member of the ME/CFS Research Roadmap Working Group and for the past several months we have been advocating on behalf of this community within this group. Our Executive Director, Laurie Jones, served on the nervous

Read More »
a rectangle image with multiple small hearts in the corners. The words, Valentine's Day Interview with Jamison Hill and Book Promotion. The cover of the book is next to the words. The #MEAction logo at the bottom.

Valentine’s Day Interview with Jamison Hill & Book Promotion

We are excited to bring you a special Valentine’s Day promotion of Jamison Hill’s most recent book, Something’s Wrong with Micah.  #MEAction had the pleasure of having a Twitter chat with Jamison when his memoir When Force Meets Fate came out. We now get to bring this Q&A about his newest book to you. Jamison

Read More »
on a red sparkly rectangle image. The words "#MEAction's Volunteer Program Revamped!" are written in an arcade/game font. Sign-Up Today! The #MEAction logo in the bottom right corner

#MEAction’s Volunteer Program Revamped

Exciting news: #MEAction revamped our volunteer program for the new year! We are honored to have wonderful volunteers including people with ME, Long Covid, and other associated conditions as well as our caregivers, allies, and wider communities. Volunteering with #MEAction can and does make all the difference. We invite you to join our program! Our

Read More »
Scroll to Top